(+/-)-3-((1R,4R)-4-((2-hydroxy-2-methyl-1-phenylpropyl)amino)cyclohexyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one | 1437789-95-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡啶类
• 英文名称: (+/-)-3-((1R,4R)-4-((2-hydroxy-2-methyl-1-phenylpropyl)amino)cyclohexyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
• 英文别名: 3-((1r,4r)-4-((2-hydroxy-2-methyl-1-phenylpropyl)amino)cyclohexyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
• CAS: 1437789-95-1
• 化学式: C₂₂H₂₈N₄O₂
• 分子量: 380.49
• InChiKey: GOYWYYLPRFQLBU-JHNFVTJISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.31
• 重原子数：
  28.0
• 可旋转键数：
  5.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  82.94
• 氢给体数：
  3.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  三光气 、 (+/-)-3-((1R,4R)-4-((2-hydroxy-2-methyl-1-phenylpropyl)amino)cyclohexyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one 在 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 0.25h， 生成 (S)-5,5-dimethyl-3-((1r,4r)-4-(2-oxo-1H-imidazo[4,5-b]pyridin-3(2H)-yl)cyclohexyl)-4-phenyloxazolidin-2-one
  参考文献：
  名称：

  Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors

  摘要：

  Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates beta-catenin concentrations, resulting in increased oncogene expression. The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of beta-catenin-mediated transcription and inhibit tumorigenesis. Compound 1 is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties. Herein, we describe the utilization of structure-based design and molecular modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (39, 40).

  DOI：

  10.1021/jm4000038
• 作为产物：
  描述：

  2-氟-3-硝基吡啶 在 zinc(II) cyanide 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 三乙酰氧基硼氢化钠 、 potassium carbonate 、 溶剂黄146 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 5.0h， 生成 (+/-)-3-((1R,4R)-4-((2-hydroxy-2-methyl-1-phenylpropyl)amino)cyclohexyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
  参考文献：
  名称：

  Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors

  摘要：

  Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates beta-catenin concentrations, resulting in increased oncogene expression. The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of beta-catenin-mediated transcription and inhibit tumorigenesis. Compound 1 is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties. Herein, we describe the utilization of structure-based design and molecular modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (39, 40).

  DOI：

  10.1021/jm4000038

文献信息

• [EN] OXAZOLIDINONE COMPOUNDS AND DERIVATIVES THEREOF<br/>[FR] COMPOSÉS D'OXAZOLIDINONE ET LEURS DÉRIVÉS
  申请人：AMGEN INC

  公开号：WO2013134079A1

  公开（公告）日：2013-09-12

  Compounds of Formula (I) and Formula (II) are useful inhibitors of tankyrase. Compounds of Formula (I) and Formula (II) have the following structure: where the definitions of the variables are provided herein.

  式(I)和式(II)的化合物是坦克酶的有用抑制剂。式(I)和式(II)的化合物具有以下结构：其中变量的定义在此提供。
• OXAZOLIDINONE COMPOUNDS AND DERIVATIVES THEREOF
  申请人：AMGEN INC.

  公开号：US20150045368A1

  公开（公告）日：2015-02-12

  Compounds of Formula (I) and Formula (II) are useful inhibitors of tankyrase. Compounds of Formula (I) and Formula (II) have the following structure: where the definitions of the variables are provided herein.

  式(I)和式(II)的化合物是坦克酰酶的有用抑制剂。式(I)和式(II)的化合物具有以下结构：其中变量的定义在此提供。
• US9340549B2
  申请人：——

  公开号：US9340549B2

  公开（公告）日：2016-05-17